Innovus Pharmaceuticals (OTC:INNV) announced today that it has inked an agreement with its current partner, Acon Laboratories, to sell Acon’s FDA-cleared glucose monitor, test strips and lancet device.
The San Diego, Calif.-based company plans to sell Acon’s glucose testing kit with its GlucoGorx glucose supplement.
Get the full story at our sister site, Drug Delivery Business News.
The post Innovus inks deal to sell Acon’s glucose monitoring kit appeared first on MassDevice.